Craft
  • Home
  •  / Pandion Therapeutics
Pandion Therapeutics

Pandion Therapeutics

Total Funding

$138 M

Pandion Therapeutics Summary

Company summary

Overview
Pandion Therapeutics is a biotechnology company developing bispecific antibody therapeutics to achieve localized immunomodulation at the site of disease for durable, tissue-specific treatment of patients with autoimmune and inflammatory disease and organ transplants. The Company is aimed to create a new generation of drugs with transformative efficacy and safety.
Type
Private
Founded
2017
HQ
Cambridge, MA, US | view all locations
Cybersecurity rating
Sectors

Key people

  • Alan Crane

    Alan Crane, Director

    • Nancy Stagliano

      Nancy Stagliano, Independent Director

      • Jo Viney

        Jo Viney, President, Chief Scientific Officer and Co-Founder

      • Don Frail

      LocationsView all

      2 locations detected

      • Cambridge, MA HQ

        United States

        610 Main St

      • Watertown, MA

        United States

        134 Coolidge Ave 2nd floor

      Blogs

      Footer menu